当前位置：　期刊中心 > 期刊介绍 > 白血病和淋巴瘤

期刊中心

Leukemia & Lymphoma
(LEUKEMIA LYMPHOMA) 《白血病和淋巴瘤》

网友评分点击次数：1538
白血病和淋巴瘤
2012年影响因子
2.301
推荐阅读

全球精选文摘

更多

全球精选全文

更多
目录导读
Published 2013年7月,Volume 54,Issue 7

最新一期

Commentaries on selected articles in this issue

free access
  Vascular endothelial growth factor expression in acute myeloid leukemia: a biomarker ready for primetime?
Ross L. Levine
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1345–1346.
Citation | Full Text | PDF (128 KB) | PDF Plus (128 KB) | Supplemental Material
free access
  Telomere 3’ overhang and disease
Bai-Wei Gu, Philip Mason
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1347–1348.
Citation | Full Text | PDF (131 KB) | PDF Plus (136 KB) | Supplemental Material
free access
  Extramedullary multiple myeloma: extraosseous relapse is extra “bad news,” but why?
Philippe Moreau, Aaron Polliack
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1349–1350.
Citation | Full Text | PDF (133 KB) | PDF Plus (134 KB) | Supplemental Material
free access
  Tyrosine kinase inhibition in acute myeloid leukemia
Jessica K. Altman, Amy K. Szilard, Leonidas C. Platanias
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1351–1352.
Citation | Full Text | PDF (133 KB) | PDF Plus (133 KB) | Supplemental Material
free access
  Targeted chemo-immunotherapy of leukemia
Khashayarsha Khazaie
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1353–1354.
Citation | Full Text | PDF (129 KB) | PDF Plus (129 KB)

Reviews

no access
Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma”
Jens Hillengass, Ola Landgren
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1355–1363.
Summary | Full Text | PDF (347 KB) | PDF Plus (348 KB) | Supplemental Material
no access
The significance of spliceosome mutations in chronic lymphocytic leukemia
Uri Rozovski, Michael Keating, Zeev Estrov
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1364–1366.
Summary | Full Text | PDF (159 KB) | PDF Plus (160 KB) | Supplemental Material
no access
The role of interleukin-9 in lymphoma
Xiao Lv, Xin Wang
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1367–1372.
Summary | Full Text | PDF (252 KB) | PDF Plus (252 KB) | Supplemental Material

Original Articles: Clinical

no access
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study
Francine M. Foss, Nelida Sjak-Shie, Andre Goy, Eric Jacobsen, Ranjana Advani, Mitchell R. Smith, Rami Komrokji, Kelly Pendergrass, Vanessa Bolejack
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1373–1379.
Summary | Full Text | PDF (232 KB) | PDF Plus (233 KB) | Supplemental Material
no access
Splenic marginal zone lymphoma: a population-based study on the 2001–2008 incidence and survival in the United States
Lihua Liu, Haijun Wang, Yiming Chen, Luis Rustveld, Gengxin Liu, Xianglin L. Du
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1380–1386.
Summary | Full Text | PDF (299 KB) | PDF Plus (300 KB) | Supplemental Material
no access
Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant
Diego Villa, Jonathan Gubbay, D. Robert Sutherland, Robert Laister, Allison McGeer, Curtis Cooper, Edgardo S. Fortuno III, Wei Xu, Lily Shi, Vishal Kukreti, Michael Crump, John Kuruvilla
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1387–1395.
Summary | Full Text | PDF (271 KB) | PDF Plus (272 KB) | Supplemental Material
no access
Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma
Yuanlin Xu, Huaqing Wang, Shiyong Zhou, Man Yu, Xianhuo Wang, Kai Fu, Zhengzi Qian,Huilai Zhang, Lihua Qiu, Xianming Liu, Ping Wang
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1396–1404.
Summary | Full Text | PDF (198 KB) | PDF Plus (199 KB) | Supplemental Material
no access
The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)
Sonali M. Smith, Heiko Schöder, Jeffrey L. Johnson, Sin-Ho Jung, Nancy L. Bartlett, Bruce D. Cheson
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1405–1410.
Summary | Full Text | PDF (275 KB) | PDF Plus (276 KB) | Supplemental Material
no access
Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009
Yiming Chen, Haijun Wang, Hagop Kantarjian, Jorge Cortes
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1411–1417.
Summary | Full Text | PDF (296 KB) | PDF Plus (297 KB) | Supplemental Material
no access
Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis
Baoping Guo, Yan Liu, Xiaohong Tan, Hong Cen
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1418–1425.
Summary | Full Text | PDF (278 KB) | PDF Plus (279 KB) | Supplemental Material
no access
Long-term effect of interferon-α combined with homoharringtonine on chronic myelogenous leukemia in chronic phase
Jiabing Zhu, Banhe Ding, Yufeng Li
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1426–1429.
Summary | Full Text | PDF (167 KB) | PDF Plus (167 KB) | Supplemental Material
no access
The clinical behavior of 124 leukemic ovarian tumors: clues for improving the poor prognosis
Isabel Cunningham
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1430–1436.
Summary | Full Text | PDF (191 KB) | PDF Plus (192 KB) | Supplemental Material
no access
Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia
Siyi Yan, Bing Han, Yongji Wu, Daobin Zhou, Yongqiang Zhao
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1437–1441.
Summary | Full Text | PDF (211 KB) | PDF Plus (212 KB) | Supplemental Material
no access
PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes
Ya-Zhen Qin, Hong-Hu Zhu, Yan-Rong Liu, Ya-Zhe Wang, Hong-Xia Shi, Yue-Yun Lai, Lan-Ping Xu, Dai-Hong Liu, Qian Jiang, Ling-Di Li, Bin Jiang, Kai-Yan Liu, Xiao-Jun Huang
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1442–1449.
Summary | Full Text | PDF (372 KB) | PDF Plus (373 KB) | Supplemental Material
no access
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Yasunori Ueda, Chisato Mizutani, Yasuhito Nannya, Mineo Kurokawa, Sumiko Kobayashi, Jin Takeuchi, Hideto Tamura, Kiyoyuki Ogata, Kazuo Dan, Hirohiko Shibayama, Yuzuru Kanakura,Keiko Niimi, Ko Sasaki, Masato Watanabe, Nobuhiko Emi, Masanao Teramura, Toshiko Motoji, Michiko Kida, Kensuke Usuki, Satoru Takada, Toru Sakura, Yoshikazu Ito, Kazuma Ohyashiki, Hiroyasu Ogawa, Takahiro Suzuki, Keiya Ozawa, Kiyotoshi Imai, Masaharu Kasai,Tomoko Hata, Yasushi Miyazaki, Yasuyoshi Morita, Akihisa Kanamaru, Akira Matsuda, Kaoru Tohyama, Daisuke Koga, Hiroya Tamaki, Kinuko Mitani, Tomoki Naoe, Haruo Sugiyama,Fumimaro Takaku
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1450–1458.
Summary | Full Text | PDF (483 KB) | PDF Plus (484 KB) | Supplemental Material
no access
Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse
Xenofon Papanikolaou, Panagiotis Repousis, Tatiana Tzenou, Dimitris Maltezas, Maria Kotsopoulou, Katerina Megalakaki, Maria Angelopoulou, Elektra Dimitrakoloulou, Efstathios Koulieris, Vassiliki Bartzis, Gerasimos Pangalis, Panagiotis Panayotidis, Marie-Christine Kyrtsonis
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1459–1464.
Summary | Full Text | PDF (199 KB) | PDF Plus (200 KB) | Supplemental Material
no access
Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma
Nicole Wong Doo, Philip A. Thompson, H. Miles Prince, John F. Seymour, David Ritchie, Kerrie Stokes, Kate Burbury, Max Wolf, Trish Joyce, Simon J. Harrison
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1465–1472.
Summary | Full Text | PDF (316 KB) | PDF Plus (317 KB) | Supplemental Material
no access
Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma
Archana Bhaskar, Ritu Gupta, Sreenivas Vishnubhatla, Lalit Kumar, Atul Sharma, Mehar Chand Sharma, Prasenjit Das, Sonu Chand Thakur
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1473–1478.
Summary | Full Text | PDF (194 KB) | PDF Plus (194 KB) | Supplemental Material
no access
Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials
Jamil N. Kanji, Michel Laverdière, Coleman Rotstein, Thomas J. Walsh, Prakesh S. Shah,Shariq Haider
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1479–1487.
Summary | Full Text | PDF (302 KB) | PDF Plus (302 KB) | Supplemental Material

Original Articles: Research

no access
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias
Bernard Bourrié, Diana L. Brassard, Sylvie Cosnier-Pucheu, Asher Zilberstein, Kin Yu, Mikhail Levit, J. Gil Morrison, Pierre Perreaut, Samir Jegham, Sandrine Hilairet, Monsif Bouaboula,Geraldine Penarier, Cécile Guiot, Philippe Larroze-Chicot, Guy Laurent, Cécile Demur, Pierre Casellas
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1488–1499.
Summary | Full Text | PDF (717 KB) | PDF Plus (718 KB) | Supplemental Material
no access
Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia
Vanessa Schneider, Stephanie Egenrieder, Marlies Götz, Cornelia Herbst, Jochen Greiner,Susanne Hofmann
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1500–1504.
Summary | Full Text | PDF (201 KB) | PDF Plus (202 KB) | Supplemental Material
no access
Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells
Aarthi Jayanthan, Todd M. Cooper, Kimberley A. Hoeksema, Shamim Lotfi, Evan Woldum,Victor A. Lewis, Aru Narendran
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1505–1516.
Summary | Full Text | PDF (665 KB) | PDF Plus (666 KB) | Supplemental Material
no access
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations
Jawad Francis, Avinash V. Dharmadhikari, Sheila N. J. Sait, George Deeb, Paul K. Wallace,James E. Thompson, Eunice S. Wang, Meir Wetzler
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1517–1520.
Summary | Full Text | PDF (219 KB) | PDF Plus (220 KB) | Supplemental Material
no access
Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia
Fang Liu, Li Gao, Yu Jing, Yuan-Yuan Xu, Yi Ding, Min-Hang Zhou, Chao Ma, Mian-Yang Li,Jun-Zhong Sun, Li-Li Wang, Li Yu
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1521–1526.
Summary | Full Text | PDF (217 KB) | PDF Plus (218 KB) | Supplemental Material
no access
Recurrent CEP85L–PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia
Nils Winkelmann, Claire Hidalgo-Curtis, Katherine Waghorn, Joannah Score, Helen Dickinson, Andrew Jack, Sahra Ali, Nicholas C. P. Cross
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1527–1531.
Summary | Full Text | PDF (267 KB) | PDF Plus (268 KB) | Supplemental Material

Letters to the Editor

no access
Rituximab administration in a community hospital environment
Nimish Shah, Simon Rule
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1532–1533.
Citation | Full Text | PDF (125 KB) | PDF Plus (126 KB) | Supplemental Material
no access
Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma
Amer Zeidan, Bishoy Faltas, William Fricke, Steven Gore, Rhett Ketterling, Ronald Sham
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1534–1537.
Citation | Full Text | PDF (226 KB) | PDF Plus (227 KB) | Supplemental Material
no access
Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Thomas Prebet, Aude Charbonnier, Véronique Gelsi-Boyer, Marie Joelle Mozziconacci, Didier Blaise, Norbert Vey
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1538–1540.
Citation | Full Text | PDF (143 KB) | PDF Plus (143 KB) | Supplemental Material
no access
Cladribine therapy in adults with advanced Langerhans cell histiocytosis
Marian Schini, Polyzois Makras, George Kanakis, Michael Voulgarelis, Gregory Kaltsas
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1541–1543.
Citation | Full Text | PDF (206 KB) | PDF Plus (207 KB) | Supplemental Material
no access
Response to lenalidomide of a patient with t(2;3)(p23;q29) and JAK2 non-mutated refractory anemia with ring sideroblasts and thrombocytosis
Min Zhang, Yong You, Xiaoqing Li, Yanli He, Jine Zheng, Weiming Li, Ping Zou, Xinyue Liu,Fang Liu
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1544–1546.
Citation | Full Text | PDF (172 KB) | PDF Plus (173 KB) | Supplemental Material
no access
Acute myeloid leukemia with monosomy 20 and diabetes insipidus: a possible novel association
Ofrat Beyar Katz, Jacob M. Rowe, Elad Schiff, Arie Oliven, Dina Attias, Tamar Tadmor
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1547–1551.
Citation | Full Text | PDF (308 KB) | PDF Plus (308 KB) | Supplemental Material
no access
TP53 mutation is rare in primary myelofibrosis
Wesley O. Greaves, Shalini Verma, Tigist Bisrat, Paolo Strati, Hamed Rahimi, Abhaya V. Paladugu, Rajyalakshmi Luthra, Keyur P. Patel, L. Jeffrey Medeiros, Hui Yao, Sherry Pierce,Carlos E. Bueso-Ramos, Srdan Verstovsek
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1552–1552.
Citation | Full Text | PDF (130 KB) | PDF Plus (131 KB) | Supplemental Material
no access
Rare coexistence of Rosai–Dorfman disease and nodal marginal zone lymphoma complicated by severe life-threatening autoimmune hemolytic anemia
Luiza Akria, Vadim Sonkin, Andrei Braester, Hector I. Cohen, Celia Suriu, Aaron Polliack
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1553–1556.
Citation | Full Text | PDF (242 KB) | PDF Plus (243 KB) | Supplemental Material
no access
Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid
Hong-Sheng Zhou, Min Dai, Yongqiang Wei, Qiang Wang, Na Xu, Changxin Yin, Fanyi Meng
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1557–1559.
Citation | Full Text | PDF (197 KB) | PDF Plus (198 KB) | Supplemental Material
no access
Human herpesvirus 8- and Epstein–Barr virus-associated solitary B cell lymphoma with a T cell immunophenotype
Henry Y. Dong, Wenjing Wang, Thomas S. Uldrick, Maryann Gangi
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1560–1563.
Citation | Full Text | PDF (384 KB) | PDF Plus (385 KB) | Supplemental Material

Correspondence

no access
Beyond race-related disparities: is myelodysplastic syndrome the same everywhere?
Silvia M. M. Magalhaes, Fabiola F. Heredia, Linette C. M. Fernandes, Paulo J. P. Almeida,Juliana C. Sousa, Geane F. Souza, Ronald F. Pinheiro
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1564–1566.
Citation | Full Text | PDF (141 KB) | PDF Plus (142 KB) | Supplemental Material
no access
A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia
Alexei Shimanovsky, Frank Bauer, Joel Silver, Samuel Lamana, Constantin A. Dasanu
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1567–1568.
Citation | Full Text | PDF (137 KB) | PDF Plus (138 KB) | Supplemental Material
free access
  On the origin of clones: learning from concurrent or sequential Philadelphia negative and positive myeloproliferative neoplasms
Ashley P. Ng
Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1569–1570.
Citation | Full Text | PDF (129 KB) | PDF Plus (130 KB) | Supplemental Material
free access
  STATEMENT OF RETRACTION

Leukemia & Lymphoma Jul 2013, Vol. 54, No. 7: 1571–1571.
Citation | Full Text | PDF (100 KB) | PDF Plus (237 KB)  | Original Article




Read More: http://informahealthcare.com/toc/lal/54/7

过刊浏览

发表评论网友评论(13)

    审稿周期： 投稿难度：
    发表评论
    LEUKEMIA LYMPHOMA 白血病和淋巴瘤
    ISSN：
    1042-8194
    出版商：
    TAYLOR & FRANCIS INC
    每年出版：
    12 期
    在线投稿
    最新一期内容
    • 期刊介绍
    • 英文介绍

    《白血病和淋巴瘤》是一种出版全长论文和评论国际期刊，涉及恶性血液病的治疗和临床实践，流行病学研究和结果分析，实验室诊断，病理学，细胞学，超微结构，细胞遗传学和细胞与分子免疫。该刊旨在一个强大的临床病理相关性。为临床医师和研究生教学提供新的和有趣的数据的信件和给编辑的信件也接受所有的主题。

    Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching.

    更多>

    同类期刊影响因子排行

    刊名　　　　　　　　　　　　　　分值